|Day Low/High||5.87 / 6.04|
|52 Wk Low/High||5.51 / 10.00|
Sonus Future Proofs KT's Network with Support for SS7 and Diameter
Sonus SBC SWe Provides Telegate with a Secure, Cost Effective Solution for Unified SIP Interconnect Management
More than three-quarters of the companies in the S&P 500 have reported results, and 66% have exceeded expectations.
We view the stock's decline on mixed quarterly results as a buying opportunity.
In recent trading, shares of Sonus Networks, Inc. have crossed above the average analyst 12-month target price of $6.75, changing hands for $6.79/share.
We closed out our position in OraSure Technologies for an average gain of 105% gain.
We used some of the proceeds to boost our stake in Jive Software this week. In addition, we initiated a position in drug-delivery system developer, Antares Pharma.
We used a price decline to add to our position in TherapeuticsMD this week.
We’d look to purchase Builders FirstSource, Jive Software and TherapeuticsMD on near-term declines.
Sonus SBC 5400 Designed to Address Unique Real-Time Communications Challenges with Security, Interoperability and Scalability
We would consider adding to TherapeuticsMD on the next market decline and booking profits in ON Semiconductor into a rally.
We didn't trade in the model portfolio this week, but several of our holdings made big moves so far this year.
We closed out a number of holdings for big gains in 2016, including McDermott, Cott and CECO Environmental.
We didn't make any trades this week but are keeping 40% of the portfolio in cash to add names as opportunities arise.
We bought more TherapeuticsMD and Yamana Gold using proceeds from the sale of some Orasure shares.
In recent trading, shares of Sonus Networks, Inc. have crossed above the average analyst 12-month target price of $6.75, changing hands for $6.77/share.
We bought shares of TherapeuticsMD but still have a large portion of the portfolio in cash.
We booked some profits in Huntington Bancshares and SLM this week and cut our rating on SLM from One to Two.
We booked some profits in Synovus Financial and used part of the proceeds to buy more Yamana Gold.
Company Sponsors Free Webinar Focused on Security, Flexibility and Performance of Real-Time Communications in the Cloud
We sold the rest of our Datalink holdings and will use the proceeds to add a name to our portfolio.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AER, AIMC, ALLY, BKU, PH, VSH Downgrades: CRAY, HMSY, OPK, SOHO, SONS, TRNC, TSRI, UTSI Initiations: CTMX, DERM Read on to get TheStreet Quant Ratings' detailed report:
We used this week's declines to add to our position in Jive Software and Sonus Networks.